These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2036036)

  • 21. Immunopathogenesis of psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2006 Aug; 47(3):151-9. PubMed ID: 16866993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis and therapy of psoriasis.
    Lowes MA; Bowcock AM; Krueger JG
    Nature; 2007 Feb; 445(7130):866-73. PubMed ID: 17314973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models of psoriasis.
    Boehncke WH; Schön MP
    Clin Dermatol; 2007; 25(6):596-605. PubMed ID: 18021898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium.
    Wolf R; Lewerenz V; Büchau AS; Walz M; Ruzicka T
    Exp Dermatol; 2007 Aug; 16(8):685-91. PubMed ID: 17620096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines and anticytokines in psoriasis.
    Pietrzak AT; Zalewska A; Chodorowska G; Krasowska D; Michalak-Stoma A; Nockowski P; Osemlak P; Paszkowski T; Roliński JM
    Clin Chim Acta; 2008 Aug; 394(1-2):7-21. PubMed ID: 18445484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
    Tonel G; Conrad C
    Int J Biochem Cell Biol; 2009 May; 41(5):963-8. PubMed ID: 19027868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pathogenesis of inflammatory dermatoses, especially psoriasis].
    Bos WE; Thio HB; Neumann HA; van der Fits L; Prens EP
    Ned Tijdschr Geneeskd; 2006 Jan; 150(4):179-83. PubMed ID: 16471231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis.
    Li HH; Lin YC; Chen PJ; Hsiao CH; Lee JY; Chen WC; Tzung TY; Wu JC; Chang MS
    Br J Dermatol; 2005 Sep; 153(3):591-5. PubMed ID: 16120148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriasis--recent advances in understanding its pathogenesis and treatment.
    Krueger G; Ellis CN
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S94-100. PubMed ID: 15968269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines: IL-20 - a new effector in skin inflammation.
    Rich BE; Kupper TS
    Curr Biol; 2001 Jul; 11(13):R531-4. PubMed ID: 11470428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine and genetic regulation of psoriasis.
    Elder JT
    Adv Dermatol; 1995; 10():99-133; discussion 134. PubMed ID: 7794681
    [No Abstract]   [Full Text] [Related]  

  • 32. [How to understand psoriasis?].
    Bérard F; Guillot I; Saad N; Nicolas JF
    Rev Prat; 2004 Jan; 54(1):28-34. PubMed ID: 15049596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis pathophysiology: current concepts of pathogenesis.
    Krueger JG; Bowcock A
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii30-6. PubMed ID: 15708932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifications of immunocompetent cells precede altered expression of epidermal differentiation antigens in psoriatic epidermis.
    Haftek M; Placek W; Thivolet J
    Acta Derm Venereol Suppl (Stockh); 1989; 146():20-5. PubMed ID: 2609869
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effector function of CLA(+) T lymphocytes on autologous keratinocytes in psoriasis].
    Ferran M; Giménez-Arnau AM; Bellosillo B; Pujol RM; Santamaría-Babi LF
    Actas Dermosifiliogr; 2008 Nov; 99(9):701-7. PubMed ID: 19087808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine-mediated communication by keratinocytes and Langerhans cells with dendritic epidermal T cells.
    Takashima A; Bergstresser PR
    Semin Immunol; 1996 Dec; 8(6):333-9. PubMed ID: 8961384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunopathogenesis of psoriatic disease].
    Perekhrestenko AP
    Lik Sprava; 2000; (5):10-4. PubMed ID: 11031438
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunopathogenesis of psoriasis.
    Sabat R; Philipp S; Höflich C; Kreutzer S; Wallace E; Asadullah K; Volk HD; Sterry W; Wolk K
    Exp Dermatol; 2007 Oct; 16(10):779-98. PubMed ID: 17845210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keratinocytes regain momentum as instigators of cutaneous inflammation.
    Nickoloff BJ
    Trends Mol Med; 2006 Mar; 12(3):102-6. PubMed ID: 16443394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell/keratinocyte interactions in psoriasis: where is the trigger?
    Simonart T; Heenen M
    Br J Dermatol; 2007 Jan; 156(1):171-2. PubMed ID: 17199589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.